Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Fetching the latest fund profile, holdings, and market data.
New York Stock Exchange Arca · Fixed Income
$21.60
−$0.015 · -0.07%
· Aug 21, 4:00 PM ET
$21.60
Previous close−$0.015 · -0.07%
· Aug 21, 4:00 PM ET
$21.60
−$0.015 · -0.07%
Regular session · ET · Market data may be delayed.
The iShares iBonds Dec 2030 Term Corporate ETF is designed to replicate the financial outcomes of an index that holds U.S. dollar-denominated, highly-rated corporate debt. These securities are specifically chosen for their 2030 maturity date. Additionally, this fund benefits from protection under U.S. Patent Numbers 8,438,100 and 8,655,770.
Fund assets
3.31B USD
Expense ratio
0.10%
NAV
$21.59
Average volume
626.77K
Volume
442.81K
Day range
$21.59 – $21.615
52-week range
$21.545 – $22.41
Previous close
$21.615
Price change
1 day
-0.07%
1 month
+0.05%
3 months
-0.64%
Year to date
-2.13%
1 year
-2.04%
3 years
+4.05%
5 years
-15.69%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Aug 23, 2026.
Portfolio composition
Fund income
Aug 3, 2026
Monthly
Aug 3, 2026
Aug 6, 2026
$0.0823
Jul 1, 2026
Monthly
Jul 1, 2026
Jul 7, 2026
$0.081
Jun 1, 2026
Monthly
Jun 1, 2026
Jun 4, 2026
$0.0823
May 1, 2026
Monthly
May 1, 2026
May 6, 2026
$0.0834
Apr 1, 2026
Monthly
Apr 1, 2026
Apr 7, 2026
$0.0819
Mar 2, 2026
Monthly
Mar 2, 2026
Mar 5, 2026
$0.0816
Feb 2, 2026
Monthly
Feb 2, 2026
Feb 5, 2026
$0.0822
Dec 19, 2025
Monthly
Dec 19, 2025
Dec 24, 2025
$0.0858
Dec 1, 2025
Monthly
Dec 1, 2025
Dec 4, 2025
$0.0823
Nov 3, 2025
Monthly
Nov 3, 2025
Nov 6, 2025
$0.0828
Latest coverage
No ETF news is currently available.
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
